Prevalence of advanced hepatic fibrosis and individualization of associated risk factors by Bayesian analysis in MASLD patients in French cardio-metabolic health networks.
The aim of this study was to determine the prevalence of advanced hepatic fibrosis and to individualize using Bayesian analysis its associated risk factors in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) being cared for in three Alsatian cardio-metabolic health netw...
Saved in:
Main Authors: | Michel Doffoel, Frédéric Chaffraix, Archia Chahard, Dominique Gras, Odile Bonomi, Corinne Bildstein, Simona Tripon, Maude Royant, Nicolas Meyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0316158 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statin prescriptions and progression of advanced fibrosis risk in primary care patients with MASLD
by: Andrew D Schreiner, et al.
Published: (2024-07-01) -
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
by: Fabrizio Termite, et al.
Published: (2025-01-01) -
The rationale for the aggressive progression of MASLD in patients with type 2 diabetes
by: Valeria Michelle Fernández-Garibay, et al.
Published: (2025-01-01) -
Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
by: Antonio Liguori, et al.
Published: (2025-01-01) -
Adipokines regulate the development and progression of MASLD through organellar oxidative stress
by: Ke Zhao, et al.
Published: (2025-02-01)